Fariba Némati

4.7k total citations · 1 hit paper
84 papers, 2.3k citations indexed

About

Fariba Némati is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Fariba Némati has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 29 papers in Oncology and 18 papers in Ophthalmology. Recurrent topics in Fariba Némati's work include Ocular Oncology and Treatments (18 papers), Ubiquitin and proteasome pathways (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Fariba Némati is often cited by papers focused on Ocular Oncology and Treatments (18 papers), Ubiquitin and proteasome pathways (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Fariba Némati collaborates with scholars based in France, Netherlands and United States. Fariba Némati's co-authors include Didier Decaudin, Patrick Couvreur, Catherine Dubernet, F. Puisieux, Sergio Roman‐Roman, Elisabetta Marangoni, Ahmed Dahmani, Marie‐France Poupon, David Gentien and Sophie Piperno‐Neumann and has published in prestigious journals such as Nature, Nature Genetics and PLoS ONE.

In The Last Decade

Fariba Némati

80 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer

2019 329 citations Kevin Grosselin, Adeline Durand et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fariba Némati France	27	1.4k	574	438	342	342	84	2.3k
Jennifer R. Allport United States	20	835 0.6×	327 0.6×	282 0.6×	154 0.5×	559 1.6×	25	2.2k
Masanobu Komatsu United States	28	1.7k 1.2×	752 1.3×	251 0.6×	93 0.3×	457 1.3×	66	2.9k
Hans W. Christinger United States	14	2.0k 1.5×	501 0.9×	403 0.9×	243 0.7×	425 1.2×	15	2.6k
Armando Bartolazzi Italy	35	2.0k 1.4×	1.1k 1.9×	460 1.1×	220 0.6×	974 2.8×	115	4.1k
Johanna Lahdenranta United States	23	2.0k 1.4×	1.4k 2.4×	618 1.4×	52 0.2×	331 1.0×	51	3.6k
Masahide Kuroki Japan	34	1.6k 1.1×	941 1.6×	408 0.9×	82 0.2×	592 1.7×	150	3.5k
Anna Borodovsky United States	24	5.0k 3.6×	1.0k 1.8×	689 1.6×	83 0.2×	1.0k 3.0×	43	6.7k
Danilo Marimpietri Italy	30	1.5k 1.1×	578 1.0×	459 1.0×	25 0.1×	412 1.2×	67	2.6k
Serena Marchiò Italy	25	990 0.7×	494 0.9×	273 0.6×	24 0.1×	285 0.8×	45	1.9k
Guillaume Normand United States	15	604 0.4×	232 0.4×	125 0.3×	88 0.3×	340 1.0×	32	1.5k

Countries citing papers authored by Fariba Némati

Since Specialization

Citations

This map shows the geographic impact of Fariba Némati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariba Némati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariba Némati more than expected).

Fields of papers citing papers by Fariba Némati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariba Némati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariba Némati. The network helps show where Fariba Némati may publish in the future.

Co-authorship network of co-authors of Fariba Némati

This figure shows the co-authorship network connecting the top 25 collaborators of Fariba Némati. A scholar is included among the top collaborators of Fariba Némati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariba Némati. Fariba Némati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aktary, Zackie, Valérie Petit, Flavie Luciani, et al.. (2025). Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin. Nature. 643(8072). 801–809. 4 indexed citations

Némati, Fariba, Fan Sun, Carine Robert, et al.. (2025). Biodegradable Polymeric Delivery Systems of Ruthenium(II) Polypyridyl Complexes for the Treatment of High-Grade Epithelial Ovarian Cancer. Chemistry of Materials. 37(22). 9231–9241.

Jolly, Christopher A., Anne‐Sophie Macé, Gabriel Champenois, et al.. (2024). TFEB triggers a matrix degradation and invasion program in triple-negative breast cancer cells upon mTORC1 repression. Developmental Cell. 60(7). 1018–1035.e8. 3 indexed citations

Gazzéri, Sylvie, Élodie Montaudon, Fariba Némati, et al.. (2024). PPP3CB overexpression mediates EGFR TKI resistance in lung tumors via calcineurin/MEK/ERK signaling. Life Science Alliance. 7(12). e202402873–e202402873. 1 indexed citations

Germini, Diego, et al.. (2024). A translational study for biomarker identification of PEP-010, a pro-apoptotic peptide restoring apoptosis in cancer models. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167492–167492. 2 indexed citations

António, João P. M., Albert Gandioso, Fariba Némati, et al.. (2022). Polymeric encapsulation of a ruthenium( ii ) polypyridyl complex: from synthesis to in vivo studies against high-grade epithelial ovarian cancer. Chemical Science. 14(2). 362–371. 20 indexed citations

Château‐Joubert, Sophie, Sophie Richon, Didier Decaudin, et al.. (2021). Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials. Translational Oncology. 14(8). 101133–101133. 7 indexed citations

Mieulet, Virginie, Yann Kieffer, Thomas Guilbert, et al.. (2021). Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer. Scientific Reports. 11(1). 4219–4219. 53 indexed citations

Jochemsen, Aart G., Annemijn P. A. Wierenga, Fariba Némati, et al.. (2020). HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma. Cancers. 12(12). 3690–3690. 28 indexed citations

10.

Grosselin, Kevin, Adeline Durand, Justine Marsolier, et al.. (2019). High-throughput single-cell ChIP-seq identifies heterogeneity of chromatin states in breast cancer. Nature Genetics. 51(6). 1060–1066. 329 indexed citations breakdown →

11.

Maire, Virginie, Fariba Némati, Laëtitia Lesage, et al.. (2019). Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers. Cancer Medicine. 8(5). 2414–2428. 57 indexed citations

12.

Némati, Fariba, Malina Xiao, Karim Maloum, et al.. (2019). Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance. Blood Advances. 3(20). 2920–2933. 9 indexed citations

13.

Gentric, Géraldine, Yann Kieffer, Virginie Mieulet, et al.. (2018). PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers. Cell Metabolism. 29(1). 156–173.e10. 197 indexed citations

14.

Gentien, David, A Duché, Audrey Rapinat, et al.. (2017). Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenografts. Pigment Cell & Melanoma Research. 30(3). 317–327. 24 indexed citations

15.

Tian, Lin, et al.. (2016). Identification of ras/raf binding site and design of interfering peptide with potential clinical application. Integrative Molecular Medicine. 3(6). 6 indexed citations

16.

Bièche, Ivan, Sophie Vacher, Sophie Richon, et al.. (2014). Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings. BMC Cancer. 14(1). 178–178. 20 indexed citations

17.

Laurent, Cécile, David Gentien, Sophie Piperno‐Neumann, et al.. (2013). Patient‐derived xenografts recapitulate molecular features of human uveal melanomas. Molecular Oncology. 7(3). 625–636. 38 indexed citations

18.

Madic, Jordan, Sophie Piperno‐Neumann, Vincent Servois, et al.. (2012). Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma. Clinical Cancer Research. 18(14). 3934–3941. 65 indexed citations

19.

Couture, Olivier, Estelle Dransart, Fariba Némati, et al.. (2011). Tumor Delivery of Ultrasound Contrast Agents Using Shiga Toxin B Subunit. Molecular Imaging. 10(2). 135–43. 25 indexed citations

20.

Pinieux, Gonzague de, Marie‐Emmanuelle Legrier, Yves Courty, et al.. (2001). Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic Approach. American Journal Of Pathology. 159(2). 753–764. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact